Oramed Pharmaceuticals Inc Long-term Investment Intensity
Oramed Pharmaceuticals Inc long-term investment intensity. Oramed Pharmaceuticals Inc (ORMP) has a Long-term Investment Intensity of 73.3% as of March 2026. Long-term investments of $197.06 Million represent 73.3% of total assets of $268.85 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read Oramed Pharmaceuticals Inc (ORMP) total liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Oramed Pharmaceuticals Inc (2020–2025)
Long-term investment intensity of Oramed Pharmaceuticals Inc from 2020 to 2025. This chart shows how Oramed Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 6 annual periods from 2020 to 2025. As of March 2026, the intensity stands at 73.3%, reflecting long-term investments of $197.06 Million against total assets of $268.85 Million USD.
Oramed Pharmaceuticals Inc Long-term Investment Intensity by Year (2020–2025)
Oramed Pharmaceuticals Inc long-term investment intensity by year from 2020 to 2025. The table below presents the year-by-year Long-term Investment Intensity for Oramed Pharmaceuticals Inc from 2020 to 2025, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see ORMP current and non-current assets.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 40.6% | $93.74 Million | $230.86 Million | ▲ +33.6 pp |
| 2024 | 7.0% | $10.91 Million | $155.28 Million | ▼ -17.9 pp |
| 2023 | 24.9% | $54.93 Million | $220.55 Million | ▲ +23.2 pp |
| 2022 | 1.7% | $2.70 Million | $161.64 Million | ▼ -3.6 pp |
| 2021 | 5.2% | $6.69 Million | $128.00 Million | ▼ -3.6 pp |
| 2020 | 8.8% | $3.93 Million | $44.63 Million | — |